103 related articles for article (PubMed ID: 18828274)
1. Immunohistochemical expression of pl30cas in papillary thyroid carcinoma.
Dilek FH; Aktepe F; Sahin DA; Topak N; Dilek ON
Int Surg; 2008; 93(3):175-80. PubMed ID: 18828274
[TBL] [Abstract][Full Text] [Related]
2. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
3. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
Sahoo S; Hoda SA; Rosai J; DeLellis RA
Am J Clin Pathol; 2001 Nov; 116(5):696-702. PubMed ID: 11710686
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis.
Karlidag T; Cobanoglu B; Keles E; Alpay HC; Ozercan I; Kaygusuz I; Yalcin S; Sakallioglu O
Am J Otolaryngol; 2007; 28(1):31-6. PubMed ID: 17162129
[TBL] [Abstract][Full Text] [Related]
6. Epithelial membrane antigen and S-100 protein expression in benign and malignant papillary thyroid neoplasms.
Kilicarslan B; Pesterelli EH; Oren N; Sargin FC; Karpuzoglu G
Adv Clin Path; 2000 Oct; 4(4):155-8. PubMed ID: 11436147
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
Omar E; Madhavan M; Othman NH
Pathology; 2004 Apr; 36(2):152-9. PubMed ID: 15203751
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma.
Koo JS; Shin E; Hong SW
APMIS; 2010 Oct; 118(10):744-52. PubMed ID: 20854468
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of the expression of S-100 protein, epithelial membrane antigen, cytokeratin and carcinoembryonic antigen in thyroid lesions.
Mitselou A; Vougiouklakis TG; Peschos D; Dallas P; Boumba VA; Agnantis NJ
Anticancer Res; 2002; 22(3):1777-80. PubMed ID: 12168868
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers.
Achille M; Boukheris H; Caillou B; Talbot M; de Vathaire F; Sabatier L; Desmaze C; Schlumberger M; Soria JC
Am J Clin Oncol; 2009 Feb; 32(1):1-8. PubMed ID: 19194115
[TBL] [Abstract][Full Text] [Related]
11. Unusual findings in papillary thyroid microcarcinoma suggesting partial regression: a study of two cases.
Simpson KW; Albores-Saavedra J
Ann Diagn Pathol; 2007 Apr; 11(2):97-102. PubMed ID: 17349567
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells.
Scarpino S; Di Napoli A; Taraboletti G; Cancrini A; Ruco LP
J Pathol; 2005 Jan; 205(1):50-6. PubMed ID: 15526350
[TBL] [Abstract][Full Text] [Related]
13. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of transketolase-like-1 in papillary thyroid carcinomas smaller than 1.5 cm in diameter is associated with lymph-node metastases.
Zerilli M; Amato MC; Martorana A; Cabibi D; Coy JF; Cappello F; Pompei G; Russo A; Giordano C; Rodolico V
Cancer; 2008 Sep; 113(5):936-44. PubMed ID: 18615628
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of histologic changes in thyroid hyperplasia: a clinicopathologic study of 300 cases.
Perez-Montiel MD; Suster S
Hum Pathol; 2008 Jul; 39(7):1080-7. PubMed ID: 18495207
[TBL] [Abstract][Full Text] [Related]
16. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
17. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
Lee J; Hasteh F
Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
[TBL] [Abstract][Full Text] [Related]
18. Altered chemokine receptor expression in papillary thyroid cancer.
González HE; Leiva A; Tobar H; Böhmwald K; Tapia G; Torres J; Mosso LM; Bueno SM; Gonzalez P; Kalergis AM; Riedel CA
Thyroid; 2009 Sep; 19(9):957-65. PubMed ID: 19731977
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
El Demellawy D; Nasr AL; Babay S; Alowami S
Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytokeratin 19 and protein p63 in fine needle aspiration biopsy of papillary thyroid carcinoma.
Bonzanini M; Amadori PL; Sagramoso C; Dalla Palma P
Acta Cytol; 2008; 52(5):541-8. PubMed ID: 18833815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]